Surveillance for Hepatocellular Carcinoma in Patients with NASH

by Philippe Kolly, Jean-François Dufour
Published 2016-06-01

Nicotinamide and NAFLD: Is There Nothing New Under the Sun?

by Maria Guarino, Jean-François Dufour
Published 2019-09-01

Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma

by Hwi Young Kim, Jean-François Dufour
Published 2020-04-01

Effects of Home Care on patients with hepatocellular carcinoma treated with sorafenib

by Monika Moser, Iuliana‐Pompilia Radu, Jean‐François Dufour
Published 2021-08-01

Macro-AST in an asymptomatic young patient

by Haithem Chtioui, Olivier Mauerhofer, Beatrice Günther, Jean-François Dufour
Published 2010-01-01

COVID-19 in Liver Transplant Recipients: A Systematic Review

by Chiara Becchetti, Sarah Gabriela Gschwend, Jean-François Dufour, Vanessa Banz
Published 2021-09-01

Antitumour necrosis factor-α agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort

by Susan Hutfless, Ruben Hernaez, Kuo-Tung Tang, Jean-François Dufour, Po-Hung Chen
Published 2020-11-01

Hepatic manifestations of drug reaction with eosinophilia and systemic symptoms syndrome

by Maria Gabriela Delgado, Stefania Casu, Matteo Montani, Felix Brunner, Nasser Semmo, Annalisa Berzigotti, Jean François Dufour
Published 2021-04-01

The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review

by Jean-François Dufour, Roger Scherer, Maria-Magdalena Balp, Sarah Jane McKenna, Nico Janssens, Patricia Lopez, Marcos Pedrosa
Published 2021-06-01

Factors affecting screening for hepatocellular carcinoma

by Farah Al Hasani, Marina Knoepfli, Armin Gemperli, Attila Kollar, Vanessa Banz, Joachim Kettenbach, Peter Jüni, Jean-François Dufour
Published 2014-03-01

Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm

by Mandy Richani, Philippe Kolly, Marina Knoepfli, Evelyn Herrmann, Martin Zweifel, Hendrik von Tengg-Kobligk, Daniel Candinas, Jean-François Dufour
Published 2016-01-01

Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease

by Cristina Margini, Giuseppe Murgia, Guido Stirnimann, Andrea De Gottardi, Nasser Semmo, Stefania Casu, Jaime Bosch, Jean‐François Dufour, Annalisa Berzigotti
Published 2018-08-01

Disruption of tumor suppressor gene Hint1 leads to remodeling of the lipid metabolic phenotype of mouse liver[S]

by Diren Beyoğlu, Kristopher W. Krausz, Juliette Martin, Olivier Maurhofer, Juliane Dorow, Uta Ceglarek, Frank J. Gonzalez, Jean-François Dufour, Jeffrey R. Idle
Published 2014-11-01

Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns

by Oriol Juanola, Mohsin Hassan, Pavitra Kumar, Bahtiyar Yilmaz, Irene Keller, Cédric Simillion, Cornelius Engelmann, Frank Tacke, Jean-François Dufour, Andrea De Gottardi, Sheida Moghadamrad
Published 2021-01-01

Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice

by Maria Guarino, Pavitra Kumar, Andrea Felser, Luigi M. Terracciano, Sergi Guixé-Muntet, Bostjan Humar, Michelangelo Foti, Jean-Marc Nuoffer, Marie V. St-Pierre, Jean-François Dufour
Published 2020-05-01

Nuclear deformation mediates liver cell mechanosensing in cirrhosis

by Sergi Guixé-Muntet, Martí Ortega-Ribera, Cong Wang, Sonia Selicean, Ion Andreu, Jenny Z. Kechagia, Constantino Fondevila, Pere Roca-Cusachs, Jean-François Dufour, Jaime Bosch, Annalisa Berzigotti, Jordi Gracia-Sancho
Published 2020-10-01

Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma

by Stephan Spahn, Daniel Roessler, Radu Pompilia, Gisela Gabernet, Beryl Primrose Gladstone, Marius Horger, Saskia Biskup, Magdalena Feldhahn, Sven Nahnsen, Franz J. Hilke, Bernhard Scheiner, Jean-François Dufour, Enrico N. De Toni, Matthias Pinter, Nisar P. Malek, Michael Bitzer
Published 2020-12-01

P62 High SVR rates with eight and twelve weeks of pangenotypic glecaprevir/pibrentasvir: integrated efficacy and safety analysis of genotype 1–6 patients without cirrhosis

by Massimo Puoti, Graham Foster, Stanley Wang, David Mutimer, Edward Gane, Christophe Moreno, Ting Tsung Chang, SamS Lee, Rui Marinho, Jean-Francois DuFour, Stanislas Pol, Christophe Hezode, Stuart C. Gordon, Simone I. Strasser, Paul J. Thuluvath, Ran Liu, Tami Pilot-Matias, Federico Mensa
Published 2017-08-01

A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C.

by Christian M Lange, Stephanie Bibert, Zoltan Kutalik, Philippe Burgisser, Andreas Cerny, Jean-Francois Dufour, Andreas Geier, Tilman J Gerlach, Markus H Heim, Raffaele Malinverni, Francesco Negro, Stephan Regenass, Klaus Badenhoop, Jörg Bojunga, Christoph Sarrazin, Stefan Zeuzem, Tobias Müller, Thomas Berg, Pierre-Yves Bochud, Darius Moradpour, Swiss Hepatitis C Cohort Study Group
Published 2012-01-01

Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort

by Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, Jan Best, Thorben Wilhelm Fründt, Carolin Czauderna, Alica Beutel, Dominik Bettinger, Johannes Weiß, Tobias Meischl, Fabian Kütting, Dirk-Thomas Waldschmidt, Pompilia Radu, Michael Schultheiß, Kai-Henrik Peiffer, Thomas J. Ettrich, Arndt Weinmann, Henning Wege, Marino Venerito, Jean-Francois Dufour, Christian M. Lange, Matthias Pinter, Oliver Waidmann
Published 2021-06-01